Evidence map›Paper›PMID 39742136›Full record

ArticleBiologics : targets & therapy2024

Zhuohui Liu, Fan Zhang, Fengfeng Jia, Shuling Li, Chaowu Jiang, Biao Ruan, Ruiqing Long

Abstract read
In one paragraph

Article in Biologics : targets & therapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Zhuohui Liu *Department of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
Fan Zhang *Department of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
Fengfeng JiaDepartment of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
Shuling LiDepartment of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
Chaowu JiangDepartment of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
Biao RuanDepartment of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
Ruiqing LongDepartment of Otolaryngology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Chronic suppurative otitis media (CSOM) is a prominent contributor to preventable hearing loss globally. Probiotic therapy has attracted research interest in human infectious and inflammatory disease. As the most prevalent probiotic, the role of Methods: RNA sequencing of granulation of middle ear cavity from CSOM patients and lavage fluid of middle ear from normal volunteer was conducted. Human middle ear epithelial cells (HMEEC) and rats infected with Results: Based on RNA Sequence analysis, a total of 3646 differentially expressed genes (1620 up-regulated and 2026 down-regulated) were identified in CSOM. RFTN1 was highly expressed in CSOM. Inhibition of RFTN1 not only reduced the inflammatory response of CSOM but also suppressed the formation of lipid rafts. Further investigation revealed that RFTN1 inhibition could reduce the expression of TLR4, which also localizes to the lipid rafts. TLR4 responds to RFTN1-mediated inflammatory responses in CSOM. We treated the CSOM model with Conclusion: In conclusion, these findings suggest a crucial role for

Indexed as

B. cereusCSOMLactobacillusRFTN1S. aureusTLR4

Identifiers

PMID39742136
PMCPMC11687115

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.